Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer – the RAPIDO trial

[1]  S. Barni,et al.  Adjuvant chemotherapy for rectal cancer. , 2015, The Lancet. Oncology.

[2]  U. Isacsson,et al.  Integrated peripheral boost in preoperative radiotherapy for the locally most advanced non-resectable rectal cancer patients , 2013, Acta oncologica.

[3]  James Yoo,et al.  Fast-track pathways in colorectal surgery. , 2013, The Surgical clinics of North America.

[4]  D. Goldstein,et al.  Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  T. Hickish,et al.  Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial , 2012, The Lancet. Oncology.

[6]  R. Labianca,et al.  ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  Jacob G. Scott,et al.  Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial , 2012 .

[8]  P. Shekelle,et al.  Screening for Colorectal Cancer , 2012, Annals of Internal Medicine.

[9]  B. Glimelius.  Multidisciplinary treatment of patients with rectal cancer: Development during the past decades and plans for the future , 2012, Upsala journal of medical sciences.

[10]  B. Glimelius,et al.  Preoperative short‐course radiotherapy with delayed surgery in primary rectal cancer , 2012, The British journal of surgery.

[11]  H. Harling,et al.  Postoperative adjuvant chemotherapy in rectal cancer operated for cure . ( Review , 2022 .

[12]  B. Glimelius,et al.  Metastatic colorectal cancer: Current treatment and future options for improved survival Medical approach – present status , 2012, Scandinavian journal of gastroenterology.

[13]  W. Hohenberger,et al.  Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  K. Bujko,et al.  Point: short-course radiation therapy is preferable in the neoadjuvant treatment of rectal cancer. , 2011, Seminars in radiation oncology.

[15]  Hein Putter,et al.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. , 2011, The Lancet. Oncology.

[16]  J. Pignon,et al.  Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  N. Petrelli,et al.  Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  D. Sargent,et al.  Adjuvant mFOLFOX6 with or without cetuxiumab (Cmab) in KRAS wild-type (WT) patients (pts) with resected stage III colon cancer (CC): Results from NCCTG Intergroup Phase III Trial N0147. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  A. Harris,et al.  Abstract A10: Upregulation of ADAM17 protease and HER ligands through a PKB negative feedback loop mediates acquired resistance to Trastuzumab in HER2 overexpressed breast cancer , 2010 .

[20]  K. Havenga,et al.  Short-course radiation therapy, neoadjuvant bevacizumab, capecitabine and oxaliplatin, and radical resection of primary tumor and metastases in primary stage IV rectal cancer: A phase II multicenter study of the Dutch Colorectal Cancer Group. , 2010 .

[21]  L. Påhlman,et al.  Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer , 2010, The British journal of surgery.

[22]  D. Nagorney,et al.  Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N9945/CI-66. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  K. Havenga,et al.  SHORT-COURSE RADIATION THERAPY, NEOADJUVANT BEVACIZUMAB, CAPECITABINE AND OXALIPLATIN, AND RADICAL RESECTION OF PRIMARY TUMOUR AND METASTASES IN PRIMARY STAGE IV RECTAL CANCER , 2010 .

[24]  N. Ferris,et al.  Preoperative staging of rectal cancer. , 2009, Future oncology.

[25]  J. Borrás,et al.  Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  A. Melcher,et al.  Short-course radiotherapy, with elective delay prior to surgery, in patients with unresectable rectal cancer who have poor performance status or significant co-morbidity. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  J. Monson,et al.  Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial , 2009, The Lancet.

[28]  Valentini,et al.  Multidisciplinary rectal cancer management , 2009 .

[29]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[30]  Gina Brown,et al.  A systematic approach to the interpretation of preoperative staging MRI for rectal cancer. , 2008, AJR. American journal of roentgenology.

[31]  M Baum,et al.  The effects of surgery on tumor growth: a century of investigations. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[32]  Lars Påhlman,et al.  Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  L. Påhlman,et al.  Short-course preoperative radiotherapy with delayed surgery in rectal cancer - a retrospective study. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  S. Larson,et al.  Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  Thomas Gruenberger,et al.  Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial , 2008, The Lancet.

[36]  B. Glimelius,et al.  The ‘good’, the ‘bad’, and the ‘ugly’ rectal cancers , 2008, Acta oncologica.

[37]  N. Smith,et al.  Preoperative staging of rectal cancer , 2008, Acta oncologica.

[38]  L. Påhlman,et al.  The Swedish rectal cancer registry , 2007, The British journal of surgery.

[39]  E. Chmielik,et al.  Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: An analysis of outcomes in a randomized trial. , 2007, International journal of radiation oncology, biology, physics.

[40]  T. Häggmark,et al.  Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer , 2007, The British journal of surgery.

[41]  Bernard Leduc,et al.  Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  Laurence Collette,et al.  Chemotherapy with preoperative radiotherapy in rectal cancer. , 2006, The New England journal of medicine.

[43]  C. V. D. van de Velde,et al.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. , 2006, The New England journal of medicine.

[44]  Andreas Makris,et al.  Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival? , 2005, International journal of radiation oncology, biology, physics.

[45]  J. Kładny,et al.  Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[46]  C. Rödel,et al.  Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO‐94 , 2003, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[47]  H. Nielsen,et al.  Recurrence and survival after mesorectal excision for rectal cancer , 2003, The British journal of surgery.

[48]  Antoni Castells,et al.  Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial , 2002, The Lancet.

[49]  H. Putter,et al.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. , 2001, The New England journal of medicine.

[50]  Leila Mohammadi,et al.  BMC Cancer , 2001 .

[51]  M. Fey.  [Adjuvant therapy for colon cancer]. , 2000, Schweizerische medizinische Wochenschrift.

[52]  L. Rutqvist,et al.  Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm , 2000, The Lancet.

[53]  L Påhlman,et al.  Improved survival with preoperative radiotherapy in resectable rectal cancer. , 1997, The New England journal of medicine.

[54]  R. Aitken,et al.  Mesorectal excision for rectal cancer , 1996, The British journal of surgery.

[55]  H. Johansson,et al.  The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma , 1995, Cancer.

[56]  D A Redelmeier,et al.  Screening for colorectal cancer. , 1995, The New England journal of medicine.

[57]  L. Påhlman,et al.  Preoperative or postoperative irradiation in adenocarcinoma of the rectum: Final treatment results of a randomized trial and an evaluation of late secondary effects , 1993, Diseases of the colon and rectum.

[58]  R. Heald,et al.  The mesorectum in rectal cancer surgery—the clue to pelvic recurrence? , 1982, The British journal of surgery.